BGIM
PCRX icon

Brandywine Global Investment Management’s Pacira BioSciences PCRX Stock Holding History

Brandywine Global Investment Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-155,413
Closed -$2.54M – 675
2024
Q3 		$2.54M Sell
155,413
-22,983
-13% -$393K 0.02% 508
2024
Q2 		$5.1M Buy
+178,396
New +$5.08M 0.04% 390

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Brandywine Global Investment Management's PCRX Position: Q4 2024 in Review

Brandywine Global Investment Management sold out of Pacira BioSciences (PCRX) in Q4 2024, closing a stake of 155,413 shares — an estimated $2.54M sold.

Brandywine Global Investment Management first reported a position in PCRX in Q2 2024 and held it in 2 quarters. The position peaked at $5.1M in Q2 2024. 233 funds tracked by Wall St. Rank hold PCRX as of Q4 2024.

  • Brandywine Global Investment Management reported no remaining Pacira BioSciences position as of Q4 2024 after selling out during the quarter.
  • Brandywine Global Investment Management sold 155,413 Pacira BioSciences shares in Q4 2024, an estimated $2.54M.
  • Brandywine Global Investment Management first reported a position in Pacira BioSciences in Q2 2024 and held it in 2 quarters.
  • Brandywine Global Investment Management's Pacira BioSciences position peaked at $5.1M in Q2 2024.
  • 233 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2024.

Based on Brandywine Global Investment Management's 13F filing for Q4 2024, filed 12 Feb 2025.